A recent study from UC San Diego reveals that frequent standing can significantly improve heart health in postmenopausal ...

New research shows that a dual treatment method of tirzepatide plus menopause hormone therapy can yield significant weight loss.

And now, a new study suggests that eating this way may also help reduce hot flashes for women during menopause. The research, ...

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...

Menopause, obesity, and diabetes will top the clinical agenda at the Endocrine Society's annual meeting, ENDO 2015, with a focus on personalized and precision approaches to disease management.

Healthcare systems and employer benefits leaders must expand their approach to obesity care, ensuring that women using GLP-1s or other weight-loss strategies are supported with Medical Nutrition ...

This hormone imbalance is one of the main reasons obesity raises the risk of endometrial cancer – especially after menopause, when progesterone levels fall naturally.

And all the more so if you have obesity. “Having excess weight during the menopause transition typically means the symptoms of perimenopause are worse,” Dr. Younglove says.

SAN FRANCISCO— Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone ...

Decreased oestrogen levels during menopause are associated with an increased risk for obesity, dyslipidaemia, hypertension and, in turn, CVD. In 2018, the European Society of Cardiology and the ...